Implanet announces grant of French patent for spine implant
Implanet announced it has been granted a patent by the French patent office protecting its Jazz Lock spine implant in France.
According to a company press release, the implant is designed to treat degenerative spine disorders, and its global market potential is estimated at more than $200 million.
“We are continuing the strict execution of our development strategy, of which the comprehensive protection of our products is a major component,” Ludovic Lastennet, chief executive officer of Implanet, said in the release. “We have submitted the dossier to various global intellectual property authorities, notably the United States. Since its limited launch last autumn in the United States and Europe, Implanet has sold more than 300 Jazz Lock implants to treat degenerative spine disorders. The clinical feedback from surgeons has been excellent, including important practical aspects such as ease of use and speed of implementation.”